GxPinnacle Logo
Skip to content

What Do Inspectors Check for Governance, Communication and Continuous Improvement in Regulatory Intelligence?

Pharmacovigilance systems must govern regulatory intelligence through structured communication, documented meetings, and continuous improvement. Regulators expect oversight, action tracking, and ongoing enhancement of the regulatory intelligence process.

For: Founders, CEOs & MDs·PV Leads·QA/Compliance·Scientists tasked with documentation

Alignment: Global pharmacovigilance principles (ICH-aligned) and inspection practices

Most useful when: Preparing for inspection, setting up a process, or closing a documentation gap

Key points

  • Regulatory intelligence must be governed through structured processes and oversight.
  • Regulatory changes must be communicated across all relevant functions.
  • Regular governance meetings must review regulatory intelligence and actions.
  • Decisions and actions must be documented and tracked.
  • Continuous improvement must ensure the regulatory intelligence process remains effective.
  • Inspection-ready evidence must demonstrate governance, communication, and ongoing enhancement of regulatory intelligence.

What inspectors expect

Each point below should be supported by controlled documents and traceable records.

  • Regulatory intelligence must be governed and documented.
  • Regulatory changes must be communicated across the organisation.
  • Meetings must review and track regulatory changes and actions.
  • Decisions must be documented and traceable.
  • The regulatory intelligence process must be continuously improved.

Summary

Inspectors assess whether regulatory intelligence is governed through structured meetings, communication processes, and continuous improvement. They review meeting records, communication of regulatory changes, and evidence that the regulatory intelligence system evolves over time.

Common questions

These are the questions this page is designed to answer directly.

  • How is regulatory intelligence governed in pharmacovigilance?
  • What do inspectors check for regulatory intelligence governance?
  • How are regulatory changes communicated in PV systems?
  • What is regulatory intelligence governance?
  • How do companies manage regulatory intelligence meetings?
  • How is regulatory intelligence communicated across teams?
  • How do regulators assess governance of regulatory changes?
  • What is continuous improvement in regulatory intelligence?
  • How do you ensure awareness of regulatory changes?
  • How do you manage regulatory intelligence meetings and decisions?

Evidence objects inspectors expect

Regulatory Intelligence Governance Meetings

  • Monthly regulatory intelligence meetings
  • Defined agenda covering new changes and actions
  • Cross-functional participation (PV, RA, QA, Clinical)
  • Documentation of discussions and decisions

Meeting Minutes and Action Records

  • Recorded meeting minutes
  • Documented decisions and approvals
  • Action items with owners and deadlines
  • Tracking of action completion

Communication of Regulatory Changes

  • Internal communications to affected teams
  • Distribution of regulatory updates
  • Training or awareness sessions following changes
  • Targeted notifications for urgent updates

Cross-Functional Coordination

  • Collaboration between PV, RA, QA, Clinical, and affiliates
  • Defined communication pathways
  • Alignment of regulatory changes across functions
  • Evidence of coordinated implementation

Continuous Improvement Records

  • Periodic review of regulatory intelligence process
  • Analysis of missed or delayed regulatory updates
  • Updates to monitoring sources or processes
  • Improvements based on audit findings or KPIs

Regulatory Basis (Primary Sources)

  • GVP Module I – requirement for PV system governance and quality oversight
  • GVP Module VI – requirement to ensure processes remain aligned with regulatory requirements
  • ICH E2E – requirement for proactive and adaptive PV systems
  • MHRA GPvP guidance – expectations for governance and communication of regulatory changes
  • FDA pharmacovigilance guidance – requirement for maintaining compliant systems through oversight

Typical Inspection Questions (What Inspectors Ask)

  • How do you govern regulatory intelligence?
  • Show me minutes of your regulatory intelligence meetings.
  • How are regulatory changes communicated to staff?
  • How do you ensure actions are followed up?
  • How do you improve your regulatory intelligence process over time?

Failure patterns

Regulatory intelligence is not governed through structured meetings.

Decisions and actions are not documented.

Regulatory changes are not communicated effectively.

Cross-functional coordination is weak or inconsistent.

No evidence of continuous improvement of the process.

What good looks like

  • Regular governance meetings reviewing regulatory intelligence.
  • Documented minutes, decisions, and action tracking.
  • Effective communication of regulatory changes across teams.
  • Strong cross-functional coordination.
  • Continuous improvement based on feedback, audits, and metrics.

Operationalisation

  • Schedule regular regulatory intelligence meetings.
  • Use structured agendas and record meeting minutes.
  • Communicate regulatory changes to all affected stakeholders.
  • Track actions and follow up on completion.
  • Review the effectiveness of the process periodically.
  • Implement improvements based on findings and feedback.

Need regulatory documentation today?

Save time and reduce inspection risk with structured, pre-built process-ready documentation.
Created by industry professionals, adaptable to your organisation.

Related pre-built documentation inside the app

Get AccessLog In

FAQ

How is regulatory intelligence governed in pharmacovigilance?

Regulatory intelligence is governed through structured meetings, defined processes, and oversight by PV and regulatory leadership.

How are regulatory changes communicated within an organisation?

Regulatory changes are communicated through meetings, internal communications, training sessions, and targeted updates to affected teams.

Do inspectors review regulatory intelligence governance?

Yes. Inspectors review governance processes, meeting records, and communication of regulatory changes.

What is continuous improvement in regulatory intelligence?

Continuous improvement involves reviewing and enhancing the regulatory intelligence process based on performance, audits, and feedback.

Why are regulatory intelligence meetings important?

Meetings ensure regulatory updates are reviewed, decisions are made, and actions are tracked across the organisation.

How do you ensure regulatory intelligence actions are completed?

By tracking actions, assigning ownership, reviewing progress in meetings, and escalating delays where necessary.

Sources

Primary guidance used to inform this map. This page is a structured interpretation layer; always validate against the original source documents.

European Medicines Agency (EMA)

  • Guideline on good pharmacovigilance practices (GVP) – Module I
    View source
  • Guideline on good pharmacovigilance practices (GVP) – Module VI
    View source

FDA

ICH

MHRA